INFOTOPIA INC
10QSB, EX-27, 2000-07-24
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: INFOTOPIA INC, 10QSB, EX-16, 2000-07-24
Next: WORLD DIAGNOSTICS INC, 10KSB/A, 2000-07-24



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>                     <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   3-MOS                   YEAR
<FISCAL-YEAR-END>                          FEB-28-2001             FEB-28-2000             FEB-28-2000
<PERIOD-END>                               MAY-31-2000             MAY-31-1999             FEB-28-2000
<CASH>                                           4,556                       0                   4,579
<SECURITIES>                                         0                       0                       0
<RECEIVABLES>                                  142,153                       0                  82,585
<ALLOWANCES>                                         0                       0                       0
<INVENTORY>                                    482,559                       0                 195,531
<CURRENT-ASSETS>                             2,156,901                       0               1,006,926
<PP&E>                                               0                       0                       0
<DEPRECIATION>                                 340,094                       0                 204,430
<TOTAL-ASSETS>                               4,807,523                       0               3,597,044
<CURRENT-LIABILITIES>                        3,175,533                       0              12,343,452
<BONDS>                                              0                       0                       0
                                0                       0                       0
                                          0                       0                       0
<COMMON>                                        20,260                       0                       0
<OTHER-SE>                                     877,194                       0                       0
<TOTAL-LIABILITY-AND-EQUITY>                 4,807,523                       0               3,597,044
<SALES>                                        871,268               1,187,684                       0
<TOTAL-REVENUES>                               498,316                 369,347                       0
<CGS>                                          372,952                 818,337                       0
<TOTAL-COSTS>                                  372,952                 369,347                       0
<OTHER-EXPENSES>                             1,834,760               2,565,337                       0
<LOSS-PROVISION>                           (1,336,444)             (1,747,000)                       0
<INTEREST-EXPENSE>                             198,188                  45,903                       0
<INCOME-PRETAX>                            (1,534,633)             (1,792,903)                       0
<INCOME-TAX>                                         0                       0                       0
<INCOME-CONTINUING>                        (1,534,633)             (1,792,903)                       0
<DISCONTINUED>                                       0                       0                       0
<EXTRAORDINARY>                                      0                       0                       0
<CHANGES>                                            0                       0                       0
<NET-INCOME>                               (1,534,633)             (1,792,903)                       0
<EPS-BASIC>                                   (0.10)                  (0.14)                       0
<EPS-DILUTED>                                        0                       0                       0





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission